Table 16.
Summary of findings on the cytotoxic and anti-tumor activity of compounds derived from Sophora species
Compound | Plant species | Cytotoxic and anti-tumor activity | Action | References |
---|---|---|---|---|
Sophoraflavanone G (19) | S. flavescens | Cytotoxicity for several tumor cells | Induces apoptosis in triple-negative breast cancer cells | Huang et al. (2019, 2020), Long et al. (2020) |
sophoraflavanone G (19), leachianone A (20), kurarinone (23), 2′-methoxykurarinone (24) |
S. flavescens S. davidii |
Cytotoxic activity | Against human myeloid leukemia HL-60 cells | Chang et al. (2019a, b), Ma et al. (2021) |
Kurarinone (23) | S. flavescens | Cytotoxic | Against human breast cancer | Boozari et al. (2019b) |
Induce apoptosis in small cell lung carcinoma | Promots Fas and TRAIL receptor-1 and -2 expression via the caspase-8/Bid pathway | Chung et al. (2019) | ||
Formononetin (125) | Suppression of tumor growth and angiogenesis | Targets the fibroblast growth factor and protein kinaseB signaling pathway | Elberry et al. (2020) | |
Exiguaflavanones A (61) and B (62) | S. exigua | Potent anti-breast cancer | MDA-MB- (-231and -468) and MCF-7 | Boozari et al. (2019b), Farhadi et al. (2019), Li et al. (2020a), Yang et al. (2020c) |
Secundiflorol D (140), secundiflorol E (141), secundiflorol A (154), secundifloran (155) | S. flavescens | Cytotoxic | Cytotoxic activity against human tumor cell lines and normal human cells | Ledoux et al. (2018), Guo et al. (2020) |
Maackiain (172) | S. alopecuroides seeds | Cytotoxic | Against MCF-7, Hep3B, HeLa and H1299 cells | Rong et al. (2020), Tsai et al. (2020) |
Leachianols (208–211) | S. leachiana | Anti-mitotic activity and cytotoxic effect | Against HeLa cells | Boozari et al. (2019a), Yang et al. (2019) |
Sophoridine (240) | S. alopecuroides | Lung cancer cell growth | Through activation of the p53 and Hippo signaling pathways | Zhou et al. (2018d, 2020), ur Rashid et al. (2020) |
Sophoridine (240) hydrochloride injection | Anticancer drugs derived fromtraditional Chinese medicine | It is indicated in nausea lymphoma, gastrointestinal tumor | Yao et al. (2021) | |
Oxysophoridine (242) | S. alopecuroides | Hepatocellular carcinoma | Suppression of the growth by regulating apoptosis associated with the Bcl-2/Bax/caspase-3 signalling pathway | Yao et al. (2012) |
Colorectal cancer cells | Suppression of the growth by regulating apoptosis associated with the Bcl-2/Bax/caspase-3 signalling pathway | Jin et al. (2017) | ||
Sophoridine (240) | S. flavescens | Gastric cancer | Upregulates CD8 + T cytotoxic function | Zhuang et al. (2020) |
Tumor-suppressive activities | This via promoting ESRRG-mediated β-catenin degradation in gastric cancer | Peng et al. (2020a, b) | ||
Oxysophocarpine (236), matrine (246) and oxymatrine (249) | Colon cancer | Anti-neoplasm mechanisms | Cao and He (2020), Elberry et al. (2020) | |
Matrine (246) | Hepatocellular carcinoma | Stronger anti-proliferative action on Bel7402 and SMMC-7721 cells under hypoxia than that in normoxia | Dai et al. (2021) | |
Colon cancer | Inhibited the proliferation and anchorage-independent growth | Fang et al. (2018) | ||
Prostate cancer |
Inhibit the progression Promoting expression of GADD45B |
Huang et al. (2018a) | ||
Myeloid leukemia | Promots human myeloid leukemia cells apoptosis | Lin et al. (2019b) | ||
Inhibits the growth of natural killer/T-cell lymphoma cells | Modulating CaMKIIγ-c-Myc signaling pathway | Gu et al. (2020) | ||
Breast cancer | Reversed multidrug resistance of MCF‐7/ADR cells through PI3K/AKT signaling pathway | Zhou et al. (2018b) | ||
Anti-proliferation | Inhibition of inhibitory κB kinase β regulation of nuclear factor κB signaling pathway | Cao and He (2020), Zhang et al. (2020a) | ||
S. moorcroftiana | Colon cancer |
Reverse the Warburg effect and suppresses cell growth Negative regulating HIF-1α Triggers colon cancer cell apoptosis and G0/G1 cell cycle arrest |
Hong et al. (2019) | |
S. alopecuroides | Gastric cancer |
Re Inhibits the progression through inhibiting miR‐93‐5p and upregulating the expression of target gene AHNAK |
Liu et al. (2020b) | |
S. flavescens | Thyroid cancer | Induces papillary thyroid cancer cell apoptosis in vitro and suppresses tumor growth in vivo by downregulating miR-182-5p | Li et al. (2019b), Fu et al. (2020) | |
Matrine (246) | Nasopharyngeal cancer |
Inhibit human nasopharyngeal carcinoma CNE-2 cells |
Wang et al. (2018c) | |
S. flavescens | Esophageal squamous cancer |
Induces apoptosis in KYSE-150 cells -Increases (ROS) and inhibiting mitochondrial function |
Jiang et al. (2018) | |
Oral squamous cancer |
Inhibits the growth of cell carcinoma cells in vitro and in vivo Exhibits it via mediation of microRNA‐22 |
Li et al. (2019d), ur Rashid et al. (2019), Liu et al. (2020b) | ||
In Compound Kushen Injection formula (S. flavescens) | Pancreatic cancer | Inhibiting autophagy‐mediated energy metabolism | Cho et al. (2018), Ao et al. (2019), Nourmohammadi et al. (2019), Yao et al. (2021) | |
Allomatrine (248) inh |
S. japonica | Inhibits proliferation and invasion | Promoting apoptosis, inducing ROS production, inhibiting ubiquitin proteasome, arresting cell cycle and regulating tumor related gene expression | Liu et al. (2020a, b) |
Matrine (246) and Oxymatrine (249) | S. flavescens | Gastric cancer |
Direct killing effects on HepG2, BEL-7402, and SGC-7901 Inhibit the invasion and metastasis of gastric cancer last cells |
Huang et al. (2018c), Elberry et al. (2020), Zhang et al. (2020a) |
Oxymatrine (249) | Apoptosis- Endothelial injury | The involvement of mitochondria-dependent apoptosis and Akt-eNOS-NO signaling pathways | Wu et al. (2019a) | |
Gastric cancer | Suppression of cell proliferation and invasion | Huang et al. (2018c) | ||
Inhibition of IL-21R-mediated JAK2/STAT3 pathway | Su et al. (2018), Fan et al. (2019) | |||
A549 human non-small lung cancer cell apoptosis | This via extrinsic and intrinsic pathways | Zhou et al. (2018d), Izdebska et al. (2019) | ||
Induces dose-dependent cell death of non-small lung cancer | This through ER stress-induced apoptosis pathway | Halim et al. (2019); Izdebska et al. (2019) | ||
Reverses epithelial-mesenchymal transition in breast cancer cells | This via depressing αVβ3 integrin/FAK/PI3K/Akt signaling activation | Chen et al. (2019c) | ||
Inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling | Reverses 5-fluorouracil resistance | Liang et al. (2020) | ||
Psoriasis vulgaris | Anti-proliferation effect on human skin keratinocytes and suppression of p63 expression | Huang et al. (2018a, b), Aly et al. (2019) | ||
N-methyl cytisine (246) | S. alopecuroides | Breast cancer | Inhibiting breast cancer cell metastasis | Chen et al. (2020a) |
Aloperine (284) | S. japonica | Colon cancer | Against multiple myeloma and colon cancer though increasing cell apoptosis | Yin et al. (2018), Li et al. (2020d) |
S. alopecuroides | Ovarian cancer | It induces apoptosis by ROS activation mechanism in human ovarian cancer cells | Qiu et al. (2020a) | |
Lung cancer | Compound 284–Adbic (adenoviral vector expressing p14ARF/p53) combined treatment on Non-small cell lung cancer cells synergistically produced induced apoptosis, anti-proliferative effects, and arrested cell cycle at the G1 phase | Muhammad et al. (2020) | ||
Bladder cancer | It significantly inhibits the viability of bladder cancer cells. This was exerted via suppressing hypoxia induced epithelial-mesenchymal transition activation of mTOR/p70S6K/4E-BP1 pathway | Zhou et al. (2020) | ||
S. flavescens | Oral squamous cancer | Through the PI3K/Akt signaling pathway | Liu et al. (2019a) | |
S. moorcroftiana | Liver cancer | Induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma | Liu et al. (2019a, 2020b) | |
Anagyrine (273) | Cytoxic activity against MCF-7 and HEPG-2 | It exhibited IC50 values of 27.3 ± 0.7 and 30.2 ± 0.9 µg/mL against MCF-7 and HEPG-2 cancer cells, respectively | Aly et al. (2021) | |
Phenolic acids (324–331) | S. tonkinensis | Cytotoxic | Against hepato-cellular carcinoma cell lines, HepG2 and Hep3B | Song et al. (2018), Hou et al. (2020) |
Butein (331) | S. tonkinensis | Cytotoxic | Inhibits the cancer cell growth | Song et al. (2018) |